Vapotherm to Report First Quarter 2021 Financial Results Reducing a Variety of Strains with Eye Yoga
Quebec’s Karma Shala Online Has The Answers MONT TREMBLANT, Quebec, April 21, 2021 (GLOBE NEWSWIRE)…
Medicenna Therapeutics Announces the Appointment of Industry Veteran, Kevin Moulder, PhD, as Chief Scientific Officer
TORONTO and HOUSTON, April 21, 2021 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the…
Chiesi Group receives European Marketing Authorization for Trimbow® inhalation powder (beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium) delivered through NEXThaler, an extrafine formulation fixed triple combination therapy for the treatment of moderate to severe COPD
Chronic obstructive pulmonary disease (COPD) patients for whom a dry powder inhaler device is preferred,…
CohBar Completes Last Subject Visit in the Phase 1b Clinical Trial for CB4211 Under Development for NASH and Obesity
MENLO PARK, Calif., April 21, 2021 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
REPEAT: Core One Labs’ Vocan Initiates Engineering and Design of a Proprietary Production System for Manufacturing of API-Grade DMT
VANCOUVER, British Columbia, April 21, 2021 (GLOBE NEWSWIRE) — Core One Labs Inc. (CSE: COOL),…
Ortho Clinical Diagnostics to Report First Quarter 2021 Results on May 5, 2021
RARITAN, N.J., April 21, 2021 (GLOBE NEWSWIRE) — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of…
Delcath Systems, Inc. Announces Revised NICE Guidance for CHEMOSAT in the United Kingdom
Recommends Special Arrangement Designation Which Increases Reimbursement Options NEW YORK, April 21, 2021 (GLOBE NEWSWIRE)…
Vericel to Report First-Quarter 2021 Financial Results on May 5, 2021
CAMBRIDGE, Mass., April 21, 2021 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced…
Allogene Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to ALLO-715, an AlloCAR T™ Cell Therapy in Development for Relapsed/Refractory Multiple Myeloma
RMAT Designation Follows Proof-of-Concept Data from ALLO-715 UNIVERSAL Trial in Heavily Pretreated, Refractory Multiple Myeloma…
WW Schedules First Quarter 2021 Earnings Conference Call
NEW YORK, April 21, 2021 (GLOBE NEWSWIRE) — WW International, Inc. (NASDAQ: WW) will release…